TP53 and neoplasm: Although the protein–protein interactions between E6 and TP-53 or pRb exhibit stronger binding energies, the relatively high affinities of apigenin and luteolin suggest that these natural compounds could effectively compete with E6, potentially preventing the degradation of these tumor suppressors.